Earnings Call · Q1 FY2025·2025-04-30

Q1 25EPS +100.00%*·Rev n/aQ4 24EPS +100.00%*·Rev n/aQ3 24EPS +100.00%*·Rev n/aQ2 24EPS +66.67%·Rev n/a⚠ consensus missing

GeneDx Holdings Corp. WGS

Sabrina Dunbar — Investor Relations (likely)

Katherine Stueland — President and Chief Executive Officer

Kevin Feeley — Chief Financial Officer

−42.8%1d on move date−42.9% vs SPY3d−42.5%5d−45.9%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more WGS calls or request research access.

More WGS calls Browse calls Request research access